Amneal Pharmaceuticals (AMRX) Net Income Growth (1y) (2018 - 2026)
Amneal Pharmaceuticals (AMRX) Net Income Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | 68.18% |
| 3 | Zoetis | 32.44 Bn | 30.50 Bn | 1.62 Bn | -0.17% |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | -384.49% |
| 5 | United Therapeutics | 23.13 Bn | 20.98 Bn | 648.10 Mn | -14.68% |
| 6 | RedHill Biopharma | 21.17 Bn | 21.17 Bn | - | - |
| 7 | Viatris | 20.33 Bn | 18.53 Bn | 1.16 Bn | 105.80% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.45 Bn | 800.70 Mn | 2,405.06% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | -14.93% |
| 10 | Amneal Pharmaceuticals | 5.68 Bn | 5.68 Bn | 320.11 Mn | 216.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 216.84% |
| Dec 31, 2025 | 339.00% |
| Sep 30, 2025 | 54.22% |
| Jun 30, 2025 | 112.13% |
| Mar 31, 2025 | 130.14% |
| Dec 31, 2024 | 77.78% |
| Sep 30, 2024 | -53.03% |
| Jun 30, 2024 | -43.40% |
| Mar 31, 2024 | -706.62% |
| Dec 31, 2023 | -1,504.68% |
| Sep 30, 2023 | 1,147.41% |
| Jun 30, 2023 | 112.35% |
| Mar 31, 2023 | -56.75% |
| Dec 31, 2022 | 71.57% |
| Sep 30, 2022 | 60.45% |
| Jun 30, 2022 | -845.20% |
| Mar 31, 2022 | -144.54% |
| Dec 31, 2021 | -187.39% |
| Sep 30, 2021 | 72.57% |
| Jun 30, 2021 | 235.60% |